Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
NICE Funding Wins For Enhertu & Kesimpta Are Firsts For England
More Data Needed Before Enhertu Can Be Made Routinely Available on NHS
21 Apr 2021
•
By
Neena Brizmohun
England's NHS will pay for new breast cancer drug and MS treatment • Source: Alamy
More from United Kingdom
More from Europe